Dudediligence.

West Pharmaceutical Services, Inc

WSTNYSE · Surgical & Medical Instruments & Apparatus
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$746.9MSep ’24$748.8MDec ’24$698.0MMar ’25$766.5MJun ’25$804.6MSep ’25$805.0MDec ’25$844.9MMar ’26$872.3MJun ’26
Net income, by quarter
$136.0MSep ’24$130.1MDec ’24$89.8MMar ’25$131.8MJun ’25$140.0MSep ’25$132.1MDec ’25$138.8MMar ’26$154.0MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$2.83B$2.89B$2.95B$2.89B$3.07B
Gross profit$1.18B$1.14B$1.13B$998.5M$1.10B
Operating income$752.3M$734.0M$676.0M$569.9M$584.9M
Net income$661.8M$585.9M$593.4M$492.7M$493.7M
Operating cash flow$584.0M$724.0M$776.5M$653.4M$754.8M
Free cash flow$330.6M$439.4M$414.5M$276.4M$468.9M
Cash$762.6M$894.3M$853.9M$484.6M$791.3M
Debt$253.0M$208.9M$206.8M$202.6M$202.8M
Shares outstanding74.2M74.1M73.5M72.3M72.0M